Clinical trial
A Phase I Double-Blind Study to Evaluate the Safety and Immunogenicity of HIV Prime/Boost Vaccine Using DNA and MVA for HIV-1/AIDS
NCT01881581 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Double-Blind Study to Evaluate the Safety and Immunogenicity of HIV Prime/Boost Vaccine Using DNA and MVA for HIV-1/AIDS
- Lead sponsor
- Centers for Disease Control and Prevention, China
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- June 30, 2013
- Completion date
- August 31, 2014
- Enrollment
- 56 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.